These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 34974373)
1. The role of ketamine-induced beta activity in the treatment of refractory status epilepticus. Is the EEG useful to determine responder's rate? A retrospective study. Machado RA; Patel J; Elsayed MS Epilepsy Behav; 2022 Feb; 127():108512. PubMed ID: 34974373 [TBL] [Abstract][Full Text] [Related]
2. Ketamine reduces seizure and interictal continuum activity in refractory status epilepticus: a multicenter in-person and teleneurocritical care study. Harnicher B; Murray NM; Dresbach J; Collingridge DS; Reachi B; Bair J; Hoang Q; Fontaine GV Neurol Sci; 2024 Nov; 45(11):5449-5456. PubMed ID: 38862653 [TBL] [Abstract][Full Text] [Related]
3. Ketamine to Prevent Endotracheal Intubation in Adults with Refractory Non-convulsive Status Epilepticus: A Case Series. Syed MJ; Zutshi D; Muzammil SM; Mohamed W Neurocrit Care; 2024 Jun; 40(3):976-983. PubMed ID: 37783825 [TBL] [Abstract][Full Text] [Related]
4. (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study. Höfler J; Rohracher A; Kalss G; Zimmermann G; Dobesberger J; Pilz G; Leitinger M; Kuchukhidze G; Butz K; Taylor A; Novak H; Trinka E CNS Drugs; 2016 Sep; 30(9):869-76. PubMed ID: 27465262 [TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children]. Wu J; Wang Q; Qian SY; Gao HM; Liu J; Deng J; Zeng JS Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):295-300. PubMed ID: 32234136 [No Abstract] [Full Text] [Related]
6. Ketamine in the treatment of refractory and super-refractory status epilepticus: Experience from two centres. García-Ruiz M; Rodríguez PM; Palliotti L; Lastras C; Romeral-Jiménez M; Morales IG; Rey CP; Rodrigo-Gisbert M; Campos-Fernández D; Santamarina E; Carbonell BP Seizure; 2024 Apr; 117():13-19. PubMed ID: 38301485 [TBL] [Abstract][Full Text] [Related]
14. Status epilepticus: Refractory and super-refractory. Dubey D; Kalita J; Misra UK Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review. Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209 [TBL] [Abstract][Full Text] [Related]
16. Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review. Dibué-Adjei M; Brigo F; Yamamoto T; Vonck K; Trinka E Brain Stimul; 2019; 12(5):1101-1110. PubMed ID: 31126871 [TBL] [Abstract][Full Text] [Related]
17. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Rossetti AO; Logroscino G; Bromfield EB Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542 [TBL] [Abstract][Full Text] [Related]
18. Use of perampanel oral suspension for the treatment of refractory and super-refractory status epilepticus. Bruschi G; Pellegrino L; Bisogno AL; Ferreri F; Kassabian B; Seppi D; Favaretto S; Corbetta M; Dainese F Epilepsy Behav; 2024 Jul; 156():109826. PubMed ID: 38761446 [TBL] [Abstract][Full Text] [Related]
19. Super-refractory status epilepticus in West China. Tian L; Li Y; Xue X; Wu M; Liu F; Hao X; Zhou D Acta Neurol Scand; 2015 Jul; 132(1):1-6. PubMed ID: 25314275 [TBL] [Abstract][Full Text] [Related]
20. Ketamine in adult super-refractory status epilepticus: Efficacy analysis on a prospective registry. Caranzano L; Novy J; Rossetti AO Acta Neurol Scand; 2022 Jun; 145(6):737-742. PubMed ID: 35274736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]